Amyloidosis Support Groups Inc
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2012 | 88,550 | 100,234 | −11,684 | 9.5 | 0% |
| 2013 | 113,911 | 77,707 | 36,204 | 17.9 | 0% |
| 2014 | 139,439 | 155,865 | −16,426 | 7.7 | 0% |
| 2015 | 272,781 | 128,257 | 144,524 | 22.8 | 0% |
| 2016 | 136,361 | 177,034 | −40,673 | 13.8 | 0% |
| 2017 | 223,843 | 137,060 | 86,783 | 25.4 | 0% |
| 2018 | 380,152 | 329,029 | 51,123 | 12.4 | 0% |
| 2019 | 410,777 | 191,900 | 218,877 | 34.8 | 0% |
| 2020 | 545,856 | 403,466 | 142,390 | 20.8 | 0% |
| 2021 | 107,843 | 64,861 | 42,982 | 137.3 | 0% |
| 2022 | 129,929 | 109,828 | 20,101 | 83.3 | 0% |
| 2023 | 271,494 | 130,946 | 140,548 | 82.7 | 0% |
| 2024 | 429,546 | 453,753 | −24,207 | 23.2 | 0% |
In its most recent public year (2024), this organization spent $24,207 more than it brought in. Its reserves stood at about 23.2 months of spending, up from 9.5 in 2012. Staff pay was 0% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2024. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Amyloidosis Support Groups Inc's IRS filings as a feed — one entry per filing year, through 2024. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works